Herbalife Ltd.
Income Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $5.04B | $4.99B | $5.06B | $5.20B | $5.80B | $5.54B | $4.88B | $4.89B |
| Cost of Revenue | $1.11B | $1.10B | $1.19B | $1.17B | $1.24B | $1.15B | $958.0M | $919.3M |
| Gross Profit | $3.92B | $3.89B | $3.87B | $4.03B | $4.56B | $4.39B | $3.92B | $3.97B |
| Gross Margin | 77.9% | 77.9% | 76.5% | 77.4% | 78.6% | 79.2% | 80.4% | 81.2% |
| Operating Expenses | ||||||||
| Research & Development | — | — | — | — | — | — | — | — |
| SG&A Expense | $1.66B | $1.88B | $1.87B | $1.81B | $2.01B | $2.08B | $1.94B | $1.96B |
| Operating Income | $481.0M | $385.9M | $356.4M | $545.2M | $734.1M | $640.6M | $568.1M | $683.1M |
| Operating Margin | 9.5% | 7.7% | 7.0% | 10.5% | 12.7% | 11.6% | 11.6% | 14.0% |
| Interest Expense | $214.4M | $218.3M | $165.9M | $139.3M | $153.1M | $133.0M | $153.0M | $181.0M |
| Pretax Income | $275.1M | $169.4M | $203.0M | $424.8M | $560.8M | $516.4M | $451.4M | $464.2M |
| Income Tax Expense | $47.3M | $-84.9M | $60.8M | $103.5M | $113.6M | $143.8M | $140.4M | $167.6M |
| Net Income | $228.3M | $254.3M | $142.2M | $321.3M | $447.2M | $372.6M | $311.0M | $296.6M |
| Net Margin | 4.5% | 5.1% | 2.8% | 6.2% | 7.7% | 6.7% | 6.4% | 6.1% |
| EPS (Basic) | $2.22 | $2.53 | $1.44 | $3.26 | $4.22 | $2.83 | $2.26 | $2.12 |
| EPS (Diluted) | $2.20 | $2.50 | $1.42 | $3.23 | $4.13 | $2.77 | $2.20 | $1.98 |
| Shares Outstanding (Basic) | 102.8M | 100.6M | 99.0M | 98.5M | 105.9M | 131.5M | 137.4M | 140.2M |
| Shares Outstanding (Diluted) | 103.6M | 101.6M | 100.2M | 99.5M | 108.3M | 134.5M | 141.6M | 149.5M |
| Dividends Per Share | — | — | — | — | — | — | — | — |